Patent · US Active

Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine

US11603353B2 · kind B2 · utility

0Cited by
4References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2022
Grant dateMar 14, 2023
Priority date—
Expiry dateAug 4, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition comprising a pharmaceutically effective amount of a pharmaceutically acceptable benzoate salt of 5-methoxy-N,N-dimethyltryptamine (5MeODMT).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.